Pfizer to allow developing nations to make generic treatment pill

Source: BBC News [UK state media]

“US drug company Pfizer has penned a deal to allow its experimental Covid-19 treatment pill to be made and sold in 95 developing nations. The deal with the UN-backed Medicines Patent Pool not-for-profit could make the treatment available to 53% of the world’s population. But it excludes several countries that have had large Covid-19 outbreaks, including Brazil. Pfizer says the pill lessens the risk of severe disease in vulnerable adults. In a statement on Tuesday, Pfizer said the agreement will allow local medicine manufacturers to produce the pill ‘with the goal of facilitating greater access to the global population.’ Pfizer will not receive royalties on sales in lower income countries and said it would waive royalties in all nations included in the agreement while Covid remains a World Health Organization-designated public health emergency.” (11/16/21)